Rasonque pancreatic cancer drug wins FDA approval

Original Article by Padmanabhan Ananthan & Christy Santhosh | Reuters | 26 August 2026

Rasonque, a pancreatic cancer treatment from Revolution Medicines, offers a new option for advanced patients. Discover its benefits.

AI Image | Chat-GPT

Rasonque, a pancreatic cancer treatment from Revolution Medicines, offers a new option for advanced patients. Discover its benefits.

Subscription Required

You must be a subscriber to access all of this content.

Already a subscriber? Log in here

Ectopic pregnancy deaths remain preventable in South Africa as delayed diagnosis and treatment expose gaps in district care.

Childhood immunisation coverage is falling sharply in SA as measles and other diseases spread. See why health officials are concerned.

Discovery’s headline earnings are expected to rise by up to 36%, supported by South African and Vitality growth.